Physician profile
Muhammad A Paracha
NPI 1619966249
$937.76
in general payments reported to CMS, 2019-2025
20 companies · $82.78 in 2025
The $82.78 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $401 · 2020: $42.91 · 2021: $103 · 2022: $176 · 2023: $17.36 · 2024: $115 · 2025: $82.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $215.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $146.18 | 2021-2024 | Hawkone |
| Abbott Laboratories | $105.76 | 2019-2025 | Esprit |
| Acumed LLC | $103.00 | 2022 | |
| Novartis Pharmaceuticals Corporation | $89.81 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $87.02 | 2019-2021 | |
| Astrazeneca Pharmaceuticals Lp | $55.04 | 2019 | |
| Boston Scientific Corporation | $52.69 | 2022 | |
| Janssen Pharmaceuticals, INC | $42.73 | 2019 | |
| Arbor Pharmaceuticals, INC. | $37.32 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.25 | 2021-2022 | |
| Bard Peripheral Vascular, INC. | $27.32 | 2019-2024 | Venclose Maven Catheter |
| Amgen INC. | $26.52 | 2019 | |
| Biocompatibles, INC. | $24.75 | 2019 | |
| Astellas Pharma US INC | $19.47 | 2019 | |
| Medtronic Vascular, INC. | $17.54 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $17.36 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.28 | 2019 | |
| Penumbra, INC. | $11.82 | 2019 | |
| Gilead Sciences, INC. | $11.67 | 2019 | |
| Cardiovascular Systems INC. | $9.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Paracha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.